They will be employed over the next 2 years to support a portfolio of 100 clinical trials.
Nationwide will specifically work with experts from The Royal Marsden School in Chelsea on the project.
The trials will aim to deliver breakthroughs in cancer treatment across radiotherapy, surgery, targeted therapy and immunotherapy.